SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Organovo (ONVO)
ONVO 2.360-12.6%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: yofal who wrote (110)11/19/2013 1:49:05 PM
From: i-node  Read Replies (1) of 171
 
It was a pretty good article. The most damning statement, in bold type in the article:

"There is precisely zero chance of Organovo reaping hundreds (or even tens) of millions of dollars in revenues over the next 3-5 years. Organovo management certainly can have no such expectations. Only the retail investors do as a result of a recent string of bullish articles. Even if an investor wants to arbitrarily double all of the assumptions above, it does not even come to $10 million cumulative revenues for the next 3 years total. Beyond 3 years, we have been given no indication when additional products will be launched."

Although not many things have a "precisely zero chance", he probably isn't too far off the mark with that statement.

The company appeals to me because they seem to be creative not only with the product but in how they're going to market it to generate some revenue along the way. It could be a very long time before the big payoff arrives, but if they can minimize the cash burn in the meantime that's about the most one can expect from them.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext